Skip to Content

🧬 Exome Sequencing

Targeting the Protein-Coding Blueprint of Life

What is Exome Sequencing?

Exome sequencing, also known as Whole Exome Sequencing (WES), is a genomic technique for sequencing all the protein-coding regions (exons) of genes in a genome. The exome makes up only 1–2% of the human genome, yet it contains approximately 85% of known disease-related mutations.

πŸ§ͺ What Does It Sequence?

The exome includes:

  • Exons: DNA sequences transcribed into mRNA and translated into proteins.
  • UTRs (sometimes included): Untranslated regions flanking the exons that regulate expression.

πŸ”¬ How Exome Sequencing Works

1. DNA Extraction

High-quality DNA is isolated from blood, saliva, or tissue samples.

2. Library Preparation & Target Capture

DNA is fragmented, and probes are used to selectively capture the exonic regions.

3. Next-Generation Sequencing (NGS)

Captured fragments are sequenced using platforms like Illumina, producing millions of short reads.

4. Bioinformatic Analysis

  • Align sequences to a reference genome
  • Detect SNPs, insertions/deletions (indels), and point mutations
  • Annotate variants using databases (ClinVar, dbSNP, etc.)

βœ… Advantages:

  • Cost-effective compared to WGS
  • High coverage of coding regions
  • Ideal for clinical diagnostics
  • Efficient for identifying rare or inherited genetic variants

🧬 Applications of Exome Sequencing

1. Rare Disease Diagnosis

  • Ideal for identifying mutations responsible for Mendelian disorders
  • Helps in diagnosing undiagnosed syndromes in children and adults

2. Cancer Genomics

  • Detects somatic mutations in coding regions of tumor DNA
  • Guides precision oncology and targeted therapies

3. Prenatal & Pediatric Testing

  • Can identify de novo mutations in developmental disorders or congenital anomalies

5. Population Genetics & Evolutionary Biology

  • Used in gene discovery, disease gene mapping, and comparative genomics

β€œExome sequencing has rapidly become the gold standard for identifying the genetic basis of Mendelian diseases.”